Pet animals and foreign travel are risk factors for colonisation with extended-spectrum b-lactamase-producing Escherichia coli

Infection

Volumn 40, Issue 6, 2012, Pages 685-687

  Meyer, E ^a,b   Gastmeier, P ^a,b   Kola, A ^a,b   Schwab, F ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b National Reference Centre for Surveillance of Nosocomial Infections   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

AFRICA; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM ISOLATION; CAT; DOG; DRUG USE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GREECE; GUINEA PIG; HUMAN; INFECTION RISK; NONHUMAN; PET ANIMAL; RISK ASSESSMENT; RISK FACTOR; SAURIAN; TRAVEL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANIMALS; BETA-LACTAMASES; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MULTIVARIATE ANALYSIS; PETS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; TRAVEL; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84874114859     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0324-8     Document Type: Article

References (16)

1. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300:371-9.
2. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315-7.
3. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165-74.
4. Rodríguez-Banõ J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamaseproducing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008;62:1142-9.
5. Wieler LH, Ewers C, Guenther S, Walther B, Lübke-Becker A. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int J Med Microbiol. 2011;301:635-41.
6. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57:441-8.
7. Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54:3564-8.
8. Strömdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011;30:1159-62.
9. Vinué L, Sáenz Y, Martínez S, Somalo S, Moreno MA, Torres C, et al. Prevalence and diversity of extended-spectrum beta-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect. 2009;15:954-7.
10. Sasaki Y, Tsujiyama Y, Kusukawa M, Murakami M, Katayama S, Yamada Y. Prevalence and characterization of Shiga toxinproducing Escherichia coli O157 and O26 in beef farms. Vet Microbiol. 2011;150:140-5.
11. Ko YJ, Moon HW, Hur M, Park CM, Cho SE, Yun YM. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Korean community and hospital settings. Infection. 2012. Epub 2012/06/23.
12. Sankar S, Narayanan H, Kuppanan S, Nandagopal B. Frequency of extended-spectrum beta-lactamase (ESBL)-producing Gramnegative bacilli in a 200-bed multi-specialty hospital in Vellore district, Tamil Nadu, India. Infection. 2012. 40:425-9.
13. Meyer E, Conrad A, Schneider C, Serr A, Babikir R, Dettenkofer M. Burden of imported cases of infection or colonization with multidrug-resistant organisms in a German university hospital. Infect Control Hosp Epidemiol. 2008;29:1195-6.
14. Meyer E, Ziegler R, Mattner F, Schwab F, Gastmeier P, Martin M. Increase of patients co-colonised or co-infected with methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium or extended-spectrum beta-lactamaseproducing Enterobacteriaceae. Infection. 2011;39:501-6.
15. Baran J Jr, Ramanathan J, Riederer KM, Khatib R. Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol. 2002;23:23-6.
16. van den Braak N, Kreft D, van Belkum A, Verbrugh H, Endtz H. Vancomycin-resistant enterococci in vegetarians. Lancet. 1997; 350:146-7.